Psychiatric Symptoms in a Patient with Influenza A (H1NI) Treated with Oseltamivir (Tamiflu): A Case Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeon, Sang Won | - |
dc.contributor.author | Han, Changsu | - |
dc.date.accessioned | 2021-09-04T13:48:52Z | - |
dc.date.available | 2021-09-04T13:48:52Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-08 | - |
dc.identifier.issn | 1738-1088 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/92848 | - |
dc.description.abstract | Oseltamivir is the most common antiviral drug used to treat and prevent influenza, Epidemiological studies performed in Japan, the United States, and the United Kingdom indicate that oseltamivir may cause psychiatric symptoms; however, the underlying mechanism has not been elucidated, In South Korea, interest in oseltamivir has increased with the spread of the new influenza virus; however, no case report or investigation of psychiatric symptoms associated with the drug has been reported to date. Here, we report a case of a 22 year old male who complained of mood swings, suicidal feelings, auditory hallucinations, memory deterioration, and insomnia after taking oseltamivir. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN COLL NEUROPSYCHOPHARMACOLOGY | - |
dc.subject | METABOLITE | - |
dc.subject | BRAIN | - |
dc.title | Psychiatric Symptoms in a Patient with Influenza A (H1NI) Treated with Oseltamivir (Tamiflu): A Case Report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, Changsu | - |
dc.identifier.doi | 10.9758/cpn.2015.13.2.209 | - |
dc.identifier.scopusid | 2-s2.0-84939492869 | - |
dc.identifier.wosid | 000360597500014 | - |
dc.identifier.bibliographicCitation | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, v.13, no.2, pp.209 - 211 | - |
dc.relation.isPartOf | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | - |
dc.citation.title | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | - |
dc.citation.volume | 13 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 209 | - |
dc.citation.endPage | 211 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002023795 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | METABOLITE | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordAuthor | Oseltamivir | - |
dc.subject.keywordAuthor | Tamiflu | - |
dc.subject.keywordAuthor | Human influenza | - |
dc.subject.keywordAuthor | Psychiatric symptom | - |
dc.subject.keywordAuthor | Side effect | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.